Avaliação das atividades antioxidante e anti-inflamatória do extrato metanólico das partes aéreas de Mitracarpus frigidus e de seu fitocomplexo supramolecular com β-ciclodextrina
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Mitracarpus Frigidus is a plant species native to South America, which has
shown potential for several biological activities, such as anti-inflammatory,
antioxidant, antimicrobial, leishmanicidal and antitumor. These activities have been
correlated to its secondary metabolites, such as alkaloids, terpenes, and phenolic
compounds. However, the instability and low solubility of natural compounds reduce
their bioavailability, interfering with the efficacy of therapy. In order to improve the
stability and bioavailability of the active components of the methanolic extract of
Mitracarpus frigidus (MFM), a supramolecular phytocomplex with β-cyclodextrin
(βCD) was developed by the co-precipitation method. Through molecular docking, it
was possible to predict a higher affinity of the compounds of interest with βCD. The
characterizations of the extract and phytocomplex by scanning electron microscopy
(SEM), infrared spectroscopy (IR), dynamic light scattering (DLS), zeta potential (ZP),
conductivity and thermal analysis (differential thermal analysis DTA and
thermogravimetric analysis TGA), demonstrated the effectiveness of the complexation
and suggested greater stability of the phytocomplex compared to the pure extract.
The antioxidant activity was evaluated by DPPH radical reduction assays, inhibition of
the β-carotene/linoleic acid system, and MDA formation, in which the phytocomplex
showed greater antioxidant potential compared to the pure extract. In vitro antiinflammatory activity was evaluated by reducing nitric oxide (NO) production and by
reducing metalloproteinases MMP2 and MMP9 activity, in J774A.1 cell line, in this
case, the phytocomplex showed better results than the pure extract again, proposing
a potential use for anti-inflammatory formulations. Both samples showed no toxicity to
the tested cell line (J774A.1).
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

